Algeria Signs Rare Disease Pact

The Algerian Ministry of Health signed a cooperation agreement with the company "Boehringer Ingelheim" to strengthen the capabilities of healthcare professionals and improve stroke and rare disease treatment systems. The agreement aims to support digitalization initiatives and the development of care pathways, contributing to the enhancement of service quality and the promotion of coordination among stakeholders in the healthcare sector, with the goal of meeting patients' needs and boosting the performance of the national health system.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article